9:45 AM · 3 October 2025

Morning wrap (03.10.2025)

  • Asia-Pacific indexes are posting modest gains. Japan’s JP225 is up +1.60%, Australia’s AU200.cash gains +0.66%, and Singapore’s SG20cash adds +0.10%. Futures on Chinese indexes are slightly lower, though the cash market remains closed due to the ongoing holiday.

  • Trump is considering issuing checks of $1,000–2,000 for all taxpayers, funded by tariff revenues. Critics note this contradicts earlier claims that tariffs would reduce the deficit.

  • Governor Ueda emphasized a flexible, data-dependent approach without giving clear signals ahead of the meeting. JPY is the weakest G10 currency today, losing around 0.20–0.30%. USDJPY is up 0.33% at 147.33.

  • Ueda expects Japan’s economic growth to slow before rebounding, with additional uncertainty stemming from tariffs. The BOJ will maintain accommodative policy until its inflation and growth forecasts materialize.

  • Japan’s unemployment rate rose to 2.6% in August versus expectations of 2.4%, while the jobs-to-applicants ratio fell to 1.20. Ueda also noted early signs of consumer spending restraint due to higher food prices.

  • September NFP data will likely be delayed, although yesterday the BLS reported it had collected all necessary data for publication.

  • If the release is postponed, markets will pay closer attention today to speeches by Fed officials including Williams, Goolsbee, Miran, Logan, and Jefferson.

  • Investors still expect a 25 bp rate cut at the end of the month, but cautious remarks from policymakers may carry greater weight in the absence of NFP.

  • Australia’s PMI weakened in September: manufacturing fell to 51.4 (from 53.0), services to 52.4 (from 55.8), and composite to 52.4. All remain above 50, indicating expansion, though momentum has slowed. September activity was the weakest since June despite continued growth.

3 October 2025, 9:47 PM

Daily Summary: US2000 leads on Wall Street📈Crypto and metals up, US dollar down

3 October 2025, 9:29 PM

BREAKING: China signals readiness for record investments in the US 🗽

3 October 2025, 6:02 PM

BREAKING: US ISM Services PMI weaker than expected 📉

3 October 2025, 3:46 PM

DE40: Europe looking for direction amid mixed PMI reports

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world